876152-40-8

Upstream product

• 130609-14-2 (R)-5-((R)-1-hydroxyethyl)dihydrofuran-2(3H)-one 
• 62-23-7 4-nitro-benzoic acid 
• 34495-74-4 Ethyl 4-hexenoate 
• 27610-27-1 5-(1-hydroxyethyl)dihydrofuran-2(3H)-one 

Downstream Products

• 1422255-64-8 (4R,5R)-benzyl 5-fluoro-4-hydroxyhexanoate 
• 1422255-65-9 (4S,5R)-benzyl 4-azido-5-fluorohexanoate 
• 1422255-68-2 (4S,5R)-5-fluoro-4-((S)-3,3,3-trifluoro-2-methoxy-2-phenylpropanamido)hexanoic acid 
• 130258-63-8 (3R,5R)-5-[(S)-1-(tert-Butyl-diphenyl-silanyloxy)-ethyl]-3-methyl-dihydro-furan-2-one 
• 130258-63-8 (3S,5R)-5-[(S)-1-(tert-Butyl-diphenyl-silanyloxy)-ethyl]-3-methyl-dihydro-furan-2-one 
• 130323-45-4 (R)-5-[(S)-1-(tert-Butyl-diphenyl-silanyloxy)-ethyl]-dihydro-furan-2-one 
• 876152-44-2 tert-Butyl-[2-((2S,3R,6S)-6-{(E)-(S)-3-[(2S,3S,5R)-5-((S)-1-methoxy-ethyl)-3-methyl-tetrahydro-furan-2-yl]-but-1-enyl}-3-methyl-tetrahydro-pyran-2-yl)-ethoxy]-diphenyl-silane 
• 876152-52-2 tert-Butyl-[2-((2S,3R,6S)-6-{(E)-(S)-3-[(2R,3S,5R)-5-((S)-1-methoxy-ethyl)-3-methyl-tetrahydro-furan-2-yl]-but-1-enyl}-3-methyl-tetrahydro-pyran-2-yl)-ethoxy]-diphenyl-silane 
• 876152-35-1 tert-Butyl-((2R,3R,6S)-6-{(E)-(S)-3-[(2S,3S,5R)-5-((S)-1-methoxy-ethyl)-3-methyl-tetrahydro-furan-2-yl]-but-1-enyl}-3-methyl-tetrahydro-pyran-2-ylmethoxy)-diphenyl-silane 
• 876152-50-0 tert-Butyl-((2R,3R,6S)-6-{(E)-(S)-3-[(2R,3S,5R)-5-((S)-1-methoxy-ethyl)-3-methyl-tetrahydro-furan-2-yl]-but-1-enyl}-3-methyl-tetrahydro-pyran-2-ylmethoxy)-diphenyl-silane 
• 876152-48-6 (S)-1-((2R,4S)-4-Methyl-5-phenylsulfanyl-tetrahydro-furan-2-yl)-ethanol 
• 876152-41-9 (3S,5R)-5-((S)-1-Methoxy-ethyl)-3-methyl-2-phenylsulfanyl-tetrahydro-furan 

Relevant academic research and scientific papers

INACTIVATORS OF TOXOPLASMA GONDII ORNITHINE AMINOTRANSFERASE FOR TREATING TOXOPLASMOSIS AND MALARIA

Disclosed are methods, compounds, and compositions for treating infection by an Apicomplexan parasite that include administering a compound that selectively inactivates ornithine aminotransferase of the Apicomplexan parasite. Specifically, the methods, co

Probing the steric requirements of the γ-aminobutyric acid aminotransferase active site with fluorinated analogues of vigabatrin

We have synthesized three analogues of 4-amino-5-fluorohexanoic acids as potential inactivators of γ-aminobutyric acid aminotransferase (GABA-AT), which were designed to combine the potency of their shorter chain analogue, 4-amino-5-fluoropentanoic acid (

Synthesis of the C14-C28 fragment of tetronasin

A synthesis of the C14-C28 fragment of Tetronasin features an S E2 reaction between a cationic η3-allylmolybdenum complex and and an α-metallated tetrahydrofuran. Georg Thieme Verlag Stuttgart.